Variable | Placebo | Combined MEDI-528 | P Valueb | ||
---|---|---|---|---|---|
n | Mean (SD) | n | Mean (SD) | ||
All subjectsa | 82 | −1.23 (0.95) | 245 | −1.22 (1.07) | 0.86 |
Asthma typea | |||||
Atopic | 70 | −1.28 (0.97) | 206 | −1.19 (1.04) | 0.55 |
Non-atopic | 12 | −0.94 (0.82) | 39 | −1.42 (1.18) | 0.41 |
ICS usea | |||||
Medium dose | 43 | −1.21 (0.97) | 117 | −1.17 (1.02) | 0.55 |
High dose | 39 | −1.26 (0.94) | 128 | −1.28 (1.11) | 0.77 |
Eosinophil counta | |||||
≥ 0.3 × 103/μL | 44 | −1.39 (0.95) | 120 | −1.17 (1.01) | 0.14 |
< 0.3 × 103/μL | 38 | −1.04 (0.92) | 124 | −1.26 (1.09) | 0.22 |
All subjects without imputation | 67 | −1.30 (0.94) | 208 | −1.28 (1.10) | 0.75 |